Evaluation of Desmin, α-SMA and hTERT expression in pulmonary fibrosis and lung cancer
Open Access
- 23 January 2018
- journal article
- Published by Heighten Science Publications Corporation in Journal of Clinical Intensive Care and Medicine
- Vol. 3 (1), 001-009
- https://doi.org/10.29328/journal.jcicm.1001011
Abstract
No abstract availableThis publication has 21 references indexed in Scilit:
- Differential telomerase expression in idiopathic pulmonary fibrosis and non-small cell lung cancerOncology Reports, 2013
- Molecular Mechanisms in Progressive Idiopathic Pulmonary FibrosisAnnual Review of Medicine, 2013
- Investigation of Telomerase/Telomeres system in Bone Marrow Mesenchymal Stem Cells derived from IPF and RA-UIPJournal of Inflammation, 2012
- Idiopathic Pulmonary Fibrosis: Update on Genetic DiscoveriesProceedings of the American Thoracic Society, 2011
- Telomere Lengths, Pulmonary Fibrosis and Telomerase (TERT) MutationsPLOS ONE, 2010
- Twist: A Regulator of Epithelial-Mesenchymal Transition in Lung FibrosisPLOS ONE, 2009
- Determinants of initiation and progression of idiopathic pulmonary fibrosisRespirology, 2009
- Telomeres and Telomerase in Lung CancerJournal of Thoracic Oncology, 2008
- Effect of TGF-?/Smad signaling pathway on lung myofibroblast differentiationActa Pharmacologica Sinica, 2007
- Telomerase expression in lung preneoplasia and neoplasiaInternational Journal of Cancer, 2007